海外の治験の状況「1」での検索結果
1852件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
- Chronic Myelogenous Leukemia;Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive);Hypereosinophilic Syndrome;Systemic Mastocytosis
- Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Netherlands, New Zealand, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2005-05-02
Not Recruiting
- International Collaborative Study of a type of epilepsy called Infantile Spasms
- Infantile spasms are a rare severe form of epilepsy affecting approx 1 in 2,250 infants, usually under the age of 1 year. Affected infants have a very abnormal EEG and a poor prognosis for subsequent epilepsy and neuro-development. There is a high risk of underlying neurological disease that independently causes delayed development and other seizure disorders. There is a high risk of a poor outcome even when there is no other detectable underlying neurological disorder.;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Germany, New Zealand, Switzerland, United Kingdom
- 2010-06-11
Not Recruiting
- SpeechATAX: Intensive home based biofeedback driven speech treatment for hereditary ataxia
- Dysarthria;Friedreich ataxia;Spinocerebellar ataxia; br>Dysarthria Friedreich ataxia Spinocerebellar ataxia;Neurological - Neurodegenerative diseases;Physical Medicine / Rehabilitation - Speech therapy;Human Genetics and Inherited Disorders - Other human genetics and inherited disorders
- Australia, Germany, New Zealand
- 2018-04-09
Not recruiting
- A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia;Non-Hodgkin Lymphoma
- Australia, United States
- 2011-04-01
Not recruiting
- Effects of sitagliptin, a dipeptidyl peptidase IV (DPP IV) inhibitor, on blood glucose and plasma incretin and insulin responses to small intestinal glucose infusion, in healthy lean and obese subjects, and alone or in combination with metformin in patients with type 2 diabetes mellitus.
- Type 2 diabetes mellitus;Incretin hormone secretion and metabolism
- Australia
- 2008-08-29
Not recruiting
- Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
- Estrogen Receptor Positive Breast Cancer;Progesterone Receptor Positive Tumor;Recurrent Breast Carcinoma;Stage IA Breast Cancer;Stage IB Breast Cancer;Stage IIA Breast Cancer;Stage IIB Breast Cancer;Stage IIIA Breast Cancer;Estrogen Receptor Positive Breast Cancer;Progesterone Receptor Positive Tumor;Recurrent Breast Carcinoma;Stage IA Breast Cancer;Stage IB Breast Cancer;Stage IIA Breast Cancer;Stage IIB Breast Cancer;Stage IIIA Breast Cancer;Estrogen Receptor Positive Breast Cancer;Progesterone Receptor Positive Tumor;Recurrent Breast Carcinoma;Stage IA Breast Cancer;Stage IB Breast Cancer;Stage IIA Breast Cancer;Stage IIB Breast Cancer;Stage IIIA Breast Cancer;Estrogen Receptor Positive Breast Cancer;Progesterone Receptor Positive Tumor;Recurrent Breast Carcinoma;Stage IA Breast Cancer;Stage IB Breast Cancer;Stage IIA Breast Cancer;Stage IIB Breast Cancer;Stage IIIA Breast Cancer
- Australia, Brazil, Canada, Chile, Germany, Hungary, India, Italy, New Zealand, Peru, South Africa, Spain, Sweden, Switzerland, United Kingdom, United States
- 2003-08-06
Not Recruiting
- Influenza, pneumococcus, and herpes zoster vaccination among patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and inflammatory bowel disease, and the effect of reminders on vaccination rates in Australian general practice
- Influenza;Pneumococcus;Herpes Zoster;Rheumatoid arthritis;Inflammatory bowel disease;Psoriatic arthritis;Ankylosing spondylitis;Crohn's Disease; Influenza Pneumococcus Herpes Zoster Rheumatoid arthritis Inflammatory bowel disease Psoriatic arthritis Ankylosing spondylitis Crohn's Disease;Public Health - Health promotion/education;Inflammatory and Immune System - Rheumatoid arthritis;Inflammatory and Immune System - Autoimmune diseases;Inflammatory and Immune System - Other inflammatory or immune system disorders;Oral and Gastrointestinal - Inflammatory bowel disease;Oral and Gastrointestinal - Crohn's disease;Infection - Other infectious diseases
- Australia
- 2019-09-04
Not Recruiting
- A phase II/III, randomized, cross-over, open-label trial to demonstrate superiority of prophylaxis over on-demand therapy in previously treated subjects with severe hemophilia A treated with plasma protein-free recombinant FVIII formulated with sucrose (BAY 81-8973)
- Severe Hemophilia-A (1% FVIII:C) MedDRA version: 13.1 Level: LLT Classification code 10060613 Term: Hemophilia A (Factor VIII) System Organ Class: 10010331 - Congenital, familial and genetic disorders MedDRA version: 13.1 Level: LLT Classification code 10053753 Term: Hemophilia A without inhibitors System Organ Class: 10010331 - Congenital, familial and genetic disorders MedDRA version: 13.1 Level: LLT Classification code 10060612 Term: Hemophilia A System Organ Class: 10010331 - Congenital, familial and genetic disorders
- Argentina, China, Colombia, Czech Republic, Japan, Mexico, Romania, Russian Federation, Serbia, South Africa, Taiwan, Turkey, Ukraine, United States
- 2010-10-13
Not Recruiting
- Adjunctive metformin in youth mood and psychotic syndromes
- cardiometabolic health parameters (blood pressure, fasting glucose, fasting insulin, cholesterol levels, body mass index and waist circumference);depressive symptoms;anxiety symptoms; cardiometabolic health parameters (blood pressure, fasting glucose, fasting insulin, cholesterol levels, body mass index and waist circumference) depressive symptoms anxiety symptoms;Metabolic and Endocrine - Metabolic disorders;Mental Health - Depression;Mental Health - Anxiety
- Australia
- 2019-11-12
Not Recruiting
- Study to investigate the benefits of an improved deferasirox formulation
- transfusion-dependent thalassemia or myelodysplastic syndrome at very low, low or intermediate (int-1) risk MedDRA version: 16.1 Level: LLT Classification code 10054658 Term: Thalassemia System Organ Class: 100000004850 MedDRA version: 16.1 Level: LLT Classification code 10028534 Term: Myelodysplastic syndrome NOS System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Austria, Belgium, Canada, France, Germany, Greece, Italy, Japan, Spain, Thailand, Tunisia, United Kingdom, United States
- 2014-03-31
Not Recruiting
- Treatment with Zoledronic acid or Tenofovir Switching in HIV-Infected
- low bone mineral density - HIV MedDRA version: 16.1 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Australia, Spain
- 2014-01-16
Not Recruiting
- A study of the pharmacokinetics, efficacy, safety, and immunogenicity of BAX-855 Administered for Prevention of Bleeding in Previously Treated Pediatric Patients with Severe Hemophilia A (a blood clotting disorder).
- Severe hemophilia A (FVIII1%) MedDRA version: 17.1 Level: LLT Classification code 10060612 Term: Hemophilia A System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Australia, Austria, Belgium, Bulgaria, Czech Republic, Germany, Hong Kong, Ireland, Japan, Korea, Republic of, Lithuania, Malaysia, Netherlands, Poland, Romania, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2014-05-23
Not Recruiting
- A study in adult patients with Cardiovascular disease or at elevated risk of having Cardiovascular disease to evaluate whether the study drug (Dalcetrapib) is able to reduce the risk of experiencing a cardiovascular event in the future such as a heart attack or a stroke by raising HDL cholesterol (also called “good”cholesterol).
- Patients with stable CHD, CHD risk equivalents (including PAD, cerebrovascular disease, and T2D), or at elevated risk for CV mortality and morbidity on the basis of multiple risk factors for CVD by raising HDL-C. MedDRA version: 14.1 Level: PT Classification code 10007649 Term: Cardiovascular disorder System Organ Class: 10007541 - Cardiac disorders ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Australia, Brazil, Bulgaria, Canada, China, Czech Republic, Denmark, France, Germany, Hungary, India, Israel, Mexico, Netherlands, Poland, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom, United States
- 2011-12-20
Not Recruiting
- A Study in Type 2 Diabetes
- Type 2 Diabetes Mellitus MedDRA version: 14.0 Level: LLT Classification code 10049746 Term: Insulin-requiring type II diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Australia, Austria, Brazil, Croatia, Czech Republic, Denmark, Germany, Greece, Hungary, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Romania, Russian Federation, Slovakia, Slovenia, Spain, Taiwan, Turkey, United Kingdom, United States
- 2011-10-12
Not recruiting
- Cholinesterase Research Outreach Project (CROP) - Measuring cholinesterase activity of western Victorian farmers
- Acetylcholinesterase inhbition ;Insulin Resistance (fasting blood sugar, OGTT);Symptoms associated with organophospate exposure: Weakness Headache Nausea Miosis Muscle twitch
- Australia
- 2013-11-15
Not Recruiting
- A Study in Type 2 Diabetes
- Type 2 Diabetes Mellitus MedDRA version: 14.0 Level: LLT Classification code 10049746 Term: Insulin-requiring type II diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Argentina, Australia, Brazil, Canada, Czech Republic, Finland, Germany, Greece, Hungary, Israel, Italy, Lithuania, Mexico, New Zealand, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Turkey, United Kingdom, United States
- 2011-09-27
Not Recruiting
- A Study in Type 2 Diabetes
- Type 2 Diabetes Mellitus MedDRA version: 14.1 Level: LLT Classification code 10049746 Term: Insulin-requiring type II diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Argentina, Australia, Brazil, Canada, Czech Republic, Finland, Germany, Greece, Hungary, Israel, Italy, Lithuania, Mexico, New Zealand, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Turkey, United Kingdom, United States
- 2011-09-19
Not recruiting
- A Randomised, Placebo Controlled, Double-Blind, Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous Doses of ATL1103 in Healthy Adult Male Subjects
- ATL1103 is being developed as a potential treatment for diseases of excessive growth hormone and insulin-like growth hormone (IGF)-I action, including the condition acromegaly.
- Australia
- 2011-08-11
Not recruiting
- Does cognitive remediation improve employment prospects for people with a mental illness returning to work?
- Schizophrenia;Schizophreniform Disorder;Bipolar 1 Disorder;Psychosis Not Otherwise Stated;Schizoaffective disorder;Delusional Disorder;Major Depressive Disorder with Psychotic features
- Australia
- 2011-08-10
Not Recruiting
- Diagnosis of psychiatric patients using data mining techniques
- Mental disorders Mental and Behavioural Disorders 1. Major depression 2. Drug-induced psychosis 3. Schizophrenia 4. Schizoaffective disorder 5. Obsessive–compulsive disorder 6. Bipolar disorder
- Egypt
- 2016-02-29
